Published in Biol Pharm Bull on July 01, 2006
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections. Nanomedicine (2013) 1.21
Folate-targeted nanoparticles show efficacy in the treatment of inflammatory arthritis. Arthritis Rheum (2011) 1.03
Real time monitoring of biomaterial-mediated inflammatory responses via macrophage-targeting NIR nanoprobes. Biomaterials (2011) 0.98
Folate-immunoglobulin G as an anticancer therapeutic antibody. Bioconjug Chem (2010) 0.78
Development of optical probes for in vivo imaging of polarized macrophages during foreign body reactions. Acta Biomater (2014) 0.76
Creation of a Long-Acting Nanoformulated 2',3'-Dideoxy-3'-Thiacytidine. J Acquir Immune Defic Syndr (2016) 0.76
Advancing musculoskeletal research with nanoscience. Nat Rev Rheumatol (2013) 0.75
Hydrophobic blocks of PEG-conjugates play a significant role in the accelerated blood clearance (ABC) phenomenon. J Control Release (2012) 1.46
Design of folate-linked liposomal doxorubicin to its antitumor effect in mice. Clin Cancer Res (2008) 1.04
Effect of polyethylene glycol linker chain length of folate-linked microemulsions loading aclacinomycin A on targeting ability and antitumor effect in vitro and in vivo. Clin Cancer Res (2005) 1.03
Preparation and characterization of superparamagnetic iron oxide nanoparticles stabilized by alginate. Int J Pharm (2006) 1.00
Folate-linked nanoparticle-mediated suicide gene therapy in human prostate cancer and nasopharyngeal cancer with herpes simplex virus thymidine kinase. Cancer Gene Ther (2005) 0.97
Enhanced antitumor effect of camptothecin loaded in long-circulating polymeric micelles. J Control Release (2006) 0.95
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting. Pharm Res (2004) 0.94
In vivo antitumor activity of camptothecin incorporated in liposomes formulated with an artificial lipid and human serum albumin. J Control Release (2008) 0.94
Selective delivery of folate-PEG-linked, nanoemulsion-loaded aclacinomycin A to KB nasopharyngeal cells and xenograft: effect of chain length and amount of folate-PEG linker. J Drug Target (2008) 0.94
Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability. Int J Pharm (2006) 0.93
Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur J Pharm Biopharm (2008) 0.92
Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr Drug Deliv (2005) 0.92
Superparamagnetic iron oxide nanoparticles stabilized by alginate: pharmacokinetics, tissue distribution, and applications in detecting liver cancers. Int J Pharm (2007) 0.92
Novel chitosan particles and chitosan-coated emulsions inducing immune response via intranasal vaccine delivery. Pharm Res (2004) 0.92
Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. J Control Release (2006) 0.92
Influence of serum and albumins from different species on stability of camptothecin-loaded micelles. J Control Release (2005) 0.92
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres. J Control Release (2006) 0.92
PEG-PLA diblock copolymer micelle-like nanoparticles as all-trans-retinoic acid carrier: in vitro and in vivo characterizations. Nanotechnology (2009) 0.90
Preparation and in vivo imaging of PEG-poly(L-lysine)-based polymeric micelle MRI contrast agents. J Control Release (2009) 0.89
Highly efficient cationic hydroxyethylated cholesterol-based nanoparticle-mediated gene transfer in vivo and in vitro in prostate carcinoma PC-3 cells. J Control Release (2007) 0.89
Adiponectin gene therapy of streptozotocin-induced diabetic mice using hydrodynamic injection. J Gene Med (2007) 0.89
siRNA delivery into tumor cells by lipid-based nanoparticles composed of hydroxyethylated cholesteryl triamine. Int J Pharm (2012) 0.88
Polymeric micelles modified by folate-PEG-lipid for targeted drug delivery to cancer cells in vitro. J Nanosci Nanotechnol (2008) 0.88
Novel irinotecan-loaded liposome using phytic acid with high therapeutic efficacy for colon tumors. J Control Release (2009) 0.88
The proximal STAT6 and NF-kappaB sites are responsible for IL-13- and TNF-alpha-induced RhoA transcriptions in human bronchial smooth muscle cells. Pharmacol Res (2009) 0.87
Accelerated blood clearance was not induced for a gadolinium-containing PEG-poly(L-lysine)-based polymeric micelle in mice. Pharm Res (2009) 0.87
Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor. Vascul Pharmacol (2012) 0.87
What are determining factors for stable drug incorporation into polymeric micelle carriers? Consideration on physical and chemical characters of the micelle inner core. J Control Release (2007) 0.87
Magnetic targeting after femoral artery administration and biocompatibility assessment of superparamagnetic iron oxide nanoparticles. J Biomed Mater Res A (2008) 0.86
Non-viral delivery of the connexin 43 gene with histone deacetylase inhibitor to human nasopharyngeal tumor cells enhances gene expression and inhibits in vivo tumor growth. Int J Oncol (2007) 0.86
Molecular characterization of tumors from a transgenic mouse adrenal tumor model: comparison with human pheochromocytoma. Int J Oncol (2010) 0.86
Organic nanotubes for drug loading and cellular delivery. Int J Pharm (2011) 0.86
Anionic polymer-coated lipoplex for safe gene delivery into tumor by systemic injection. J Drug Target (2013) 0.86
Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines. Int J Pharm (2005) 0.86
Involvement of transcription factor Ets-1 in the expression of the α3 integrin subunit gene. FEBS J (2012) 0.86
Enhanced antitumor efficacy of folate-linked liposomal doxorubicin with TGF-β type I receptor inhibitor. Cancer Sci (2010) 0.85
Sustained release of cisplatin from multivesicular liposomes: potentiation of antitumor efficacy against S180 murine carcinoma. J Pharm Sci (2004) 0.85
Combination therapy with gefitinib and doxorubicin inhibits tumor growth in transgenic mice with adrenal neuroblastoma. Cancer Med (2013) 0.84
Functional coating of liposomes using a folate- polymer conjugate to target folate receptors. Int J Nanomedicine (2012) 0.84
Development of high boron content liposomes and their promising antitumor effect for neutron capture therapy of cancers. Bioconjug Chem (2012) 0.84
Collagenase-1 injection improved tumor distribution and gene expression of cationic lipoplex. Int J Pharm (2011) 0.84
Effects of polyethylene glycol spacer length and ligand density on folate receptor targeting of liposomal Doxorubicin in vitro. J Drug Deliv (2010) 0.84
Polymer design and incorporation methods for polymeric micelle carrier system containing water-insoluble anti-cancer agent camptothecin. J Drug Target (2004) 0.83
High gene delivery in tumor by intratumoral injection of tetraarginine-PEG lipid-coated protamine/DNA. J Control Release (2008) 0.83
Enhanced in vitro DNA transfection efficiency by novel folate-linked nanoparticles in human prostate cancer and oral cancer. J Control Release (2004) 0.83
Combination of non-viral connexin 43 gene therapy and docetaxel inhibits the growth of human prostate cancer in mice. Int J Oncol (2007) 0.83
Higher liposomal membrane fluidity enhances the in vitro antitumor activity of folate-targeted liposomal mitoxantrone. Mol Pharm (2009) 0.83
Stability and antitumor effects of all-trans retinoic acid-loaded liposomes contained sterylglucoside mixture. Int J Pharm (2003) 0.83
p-Dodecylaminophenol derived from the synthetic retinoid, fenretinide: antitumor efficacy in vitro and in vivo against human prostate cancer and mechanism of action. Int J Cancer (2008) 0.82
Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid, oleic acid, vitamin E and cholesterol. Int J Pharm (2003) 0.82
Adrenal tumor volume in a genetically engineered mouse model of neuroblastoma determined by magnetic resonance imaging. Exp Ther Med (2012) 0.82
Cell line-dependent internalization pathways determine DNA transfection efficiency of decaarginine-PEG-lipid. Int J Pharm (2010) 0.82
Octreotide-targeted liposomes loaded with CPT-11 enhanced cytotoxicity for the treatment of medullary thyroid carcinoma. Mol Pharm (2011) 0.81
Novel ultra-deformable vesicles entrapped with bleomycin and enhanced to penetrate rat skin. J Control Release (2006) 0.81
Two-step transcriptional amplification-lipid-based nanoparticles using PSMA or midkine promoter for suicide gene therapy in prostate cancer. Cancer Sci (2006) 0.81
Long-circulating liposome-encapsulated ganciclovir enhances the efficacy of HSV-TK suicide gene therapy. J Control Release (2007) 0.81
Development of an in vitro drug release assay of PEGylated liposome using bovine serum albumin and high temperature. Biol Pharm Bull (2010) 0.81
Combination of RET siRNA and irinotecan inhibited the growth of medullary thyroid carcinoma TT cells and xenografts via apoptosis. Cancer Sci (2010) 0.80
Preparation and pharmacokinetics of pirarubicin loaded dehydration-rehydration vesicles. Int J Pharm (2003) 0.80
Antitumor effects and pharmacokinetics of aclacinomycin A carried by injectable emulsions composed of vitamin E, cholesterol, and PEG-lipid. J Pharm Sci (2002) 0.80
Angiotensin II-induced hypertension enhanced therapeutic efficacy of liposomal doxorubicin in tumor-bearing mice. Int J Pharm (2010) 0.79
Upregulation of ADAM8 in the airways of mice with allergic bronchial asthma. Lung (2009) 0.79
The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy. J Gene Med (2006) 0.79
Direct evidence for the ongoing brain activation by enhanced dynorphinergic system in the spinal cord under inflammatory noxious stimuli. Anesthesiology (2010) 0.79
Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics. J Control Release (2010) 0.79
Preparation and in vivo evaluation of liposomal everolimus for lung carcinoma and thyroid carcinoma. Biol Pharm Bull (2012) 0.78
Effects of organic solvents on drug incorporation into polymeric carriers and morphological analyses of drug-incorporated polymeric micelles. Int J Pharm (2010) 0.78
Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. Int J Pharm (2007) 0.78
Intracellular delivery of proteins in complexes with oligoarginine-modified liposomes and the effect of oligoarginine length. Bioconjug Chem (2006) 0.78
Liver targeting liposomes containing beta-sitosterol glucoside with regard to penetration-enhancing effect on HepG2 cells. Biol Pharm Bull (2002) 0.77
Folate-targeted gadolinium-lipid-based nanoparticles as a bimodal contrast agent for tumor fluorescent and magnetic resonance imaging. Biol Pharm Bull (2014) 0.77
Dual functional octreotide-modified liposomal irinotecan leads to high therapeutic efficacy for medullary thyroid carcinoma xenografts. Cancer Sci (2011) 0.77
Decaarginine-PEG-liposome enhanced transfection efficiency and function of arginine length and PEG. Int J Pharm (2008) 0.77
Surface properties of lipoplexes modified with mannosylerythritol lipid-a and tween 80 and their cellular association. Chem Pharm Bull (Tokyo) (2009) 0.77
DNA/Lipid complex incorporated with fibronectin to cell adhesion enhances transfection efficiency in prostate cancer cells and xenografts. Biol Pharm Bull (2007) 0.77
Non-ionic surfactant modified cationic liposomes mediated gene transfection in vitro and in the mouse lung. Biol Pharm Bull (2009) 0.77
Low-molecular-weight polyethylenimine enhanced gene transfer by cationic cholesterol-based nanoparticle vector. Biol Pharm Bull (2007) 0.77
Design, synthesis and gene delivery efficiency of novel oligo-arginine-linked PEG-lipids: effect of oligo-arginine length. Int J Pharm (2006) 0.77
NaCl induced high cationic hydroxyethylated cholesterol-based nanoparticle-mediated synthetic small interfering RNA transfer into prostate carcinoma PC-3 cells. Biol Pharm Bull (2008) 0.76
Decaarginine-PEG-artificial lipid/DNA complex for gene delivery: nanostructure and transfection efficiency. J Nanosci Nanotechnol (2008) 0.76
mRNA delivery through fibronectin associated liposome-apatite particles: a new approach for enhanced mRNA transfection to mammalian cell. Biol Pharm Bull (2012) 0.76
Cholesteryl hemisuccinate as a membrane stabilizer in dipalmitoylphosphatidylcholine liposomes containing saikosaponin-d. Int J Pharm (2005) 0.76
Menthosomes, novel ultradeformable vesicles for transdermal drug delivery: optimization and characterization. Biol Pharm Bull (2012) 0.76
Regional intestinal absorption of FITC-dextran 4,400 with nanoparticles based on beta-sitosterol beta-D-glucoside in rats. J Pharm Sci (2003) 0.75
Implication of spinal protein kinase Cgamma isoform in activation of the mouse brain by intrathecal injection of the protein kinase C activator phorbol 12,13-dibutyrate using functional magnetic resonance imaging analysis. Neurosci Lett (2007) 0.75
Formulation optimization of paclitaxel carried by PEGylated emulsions based on artificial neural network. Pharm Res (2004) 0.75
Polymer combination increased both physical stability and oral absorption of solid dispersions containing a low glass transition temperature drug: physicochemical characterization and in vivo study. Chem Pharm Bull (Tokyo) (2012) 0.75
Antitumor effect of liposomal histone deacetylase inhibitor-lipid conjugates in vitro. Chem Pharm Bull (Tokyo) (2011) 0.75
Early entry and deformation of macropinosomes correlates with high efficiency of decaarginine-polyethylene glycol-lipid-mediated gene delivery. J Gene Med (2012) 0.75
Enhanced plasmid DNA transfer into tumor cells by nanoparticle composed of cholesteryl triamine and diamine. Biol Pharm Bull (2013) 0.75
NaCl improves siRNA delivery mediated by nanoparticles of hydroxyethylated cationic cholesterol with amido-linker. Bioorg Med Chem Lett (2008) 0.75
Tumor environment changed by combretastatin derivative (Cderiv) pretreatment that leads to effective tumor targeting, MRI studies, and antitumor activity of polymeric micelle carrier systems. Pharm Res (2011) 0.75
Increase of the therapeutic effect by treating nasopharyngeal tumor with combination of HER-2 siRNA and paclitaxel. Int J Oncol (2010) 0.75
Influence of manufacturing factors on physical stability and solubility of solid dispersions containing a low glass transition temperature drug. Chem Pharm Bull (Tokyo) (2012) 0.75
The distribution of mRNA expression and protein after hydrodynamic injection of transgene in mice. Biol Pharm Bull (2009) 0.75
Histone deacetylase inhibitor prodrugs in nanoparticle vector enhanced gene expression in human cancer cells. Eur J Med Chem (2009) 0.75
Biosurfactant MEL-A enhances cellular association and gene transfection by cationic liposome. J Control Release (2006) 0.75
[Tumor permeability of nanocarriers observed by dynamic contrast-enhanced magnetic resonance imaging]. Yakugaku Zasshi (2010) 0.75
Characteristics and biodistribution of soybean sterylglucoside and polyethylene glycol-modified cationic liposomes and their complexes with antisense oligodeoxynucleotide. Drug Deliv (2005) 0.75